Irving Hoffman has been on the UNC faculty since 1992. He has provided technical assistance to HIV and STI control programs in over fifteen countries in Africa, Asia and the Caribbean. He is the Director of International Operations for the IGHID and oversees the growth of the UNC academic centers in Malawi, Vietnam, Zambia, Nicaragua and China. He started UNC Project, Malawi with Mike Cohen and for the past 25 years, since its inception, he has been the international director of the UNC Project in Lilongwe. Hoffman is an author of over 260 peer-reviewed publications. He was a key investigator in HPTN 052 that proved the power of HIV treatment as prevention; he led the team in Malawi that tested the first partially effective malaria vaccine, RTSS. Hoffman was the co-chair of HPTN 074, a study among people who inject drugs conducted in Vietnam Indonesia and Ukraine that proved the efficacy of facilitated ART and drug abuse treatment on HIV transmission and survival. In Malawi he is currently the PI of a phase III gonorrhea vaccine trial; a programmatic grant in support of the Malawi Antimicrobial Resistance (AMR) Program; and a gonorrhea AMR surveillance program with the WHO.